Medicine guide
Lytenava
1.25 mg · Injection
- Prescription only
- Vascular Endothelial Growth Factor Inhibitor
- Active substance
- Bevacizumab-Vikg
- Made by
- Outlook Therapeutics, Inc.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Outlook Therapeutics, Inc. |
|---|---|
| Active substance | Bevacizumab-Vikg |
| Strength | 1.25 mg |
| Form | Injection |
| Route | Intravitreal |
| Packs | 1 VIAL, GLASS in 1 CARTON / 1 INJECTION in 1 VIAL, GLASS |
| NDC | 82491-025 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).